首页> 外国专利> TISSUE AND BLOOD-BASED MIRNA BIOMARKERS FOR THE DIAGNOSIS, PROGNOSIS AND METASTASIS-PREDICTIVE POTENTIAL IN COLORECTAL CANCER

TISSUE AND BLOOD-BASED MIRNA BIOMARKERS FOR THE DIAGNOSIS, PROGNOSIS AND METASTASIS-PREDICTIVE POTENTIAL IN COLORECTAL CANCER

机译:组织和血液中的miRNA生物标志物在大肠癌中的诊断,预测和转移预测潜能

摘要

Methods and compositions for the diagnosis, prognosis and classification of cancer, especially colorectal cancer, are provided. For example, in certain aspects methods for cancer prognosis using expression or methylation analysis of selected biomarkers are described. Particular aspects of the present invention may include methods and biomarkers for diagnosing or detecting colorectal cancer or metastasis in a subject by measuring a level of expression of biomarker miRNA such as miR-885-5p in the sample from the subject and evaluating the risk of developing cancer or metastasis in the subject.
机译:提供了用于癌症,特别是结直肠癌的诊断,预后和分类的方法和组合物。例如,在某些方面,描述了使用所选生物标志物的表达或甲基化分析的癌症预后方法。本发明的特定方面可以包括用于通过测量来自受试者的样品中的生物标志物miRNA(例如miR-885-5p)的表达水平并评估其发展的风险来诊断或检测受试者中的结肠直肠癌或转移的方法和生物标志物。受试者的癌症或转移。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号